Search results for "venom"

showing 10 items of 63 documents

Venom gland and reservoir morphology in the Doryctinae and related braconid wasps (Insecta, Hymenoptera, Braconidae)

1992

Detailed venom reservoir and venom gland intima morphology has been investigated in reprsentatives of 84 genera and 10 subfamilies of Braconidae with particular reference to the Doryctinac, basal cyclostomes and related groups including the Opiinae, Alysiinae and Rogadinae sens. lat. Several new phylogenetically significant characters are described and illustrated. Extcnsivc secretory ductules on the primary venom duct is suggested as a synapomorphy for the subfamilies Braconinac, Doryctinae, Opiinae, Alysiinae and Gnamptodontinae. The presence of two separate venom gland insertions and their position beyond the spiral sculpture of the reservoir are suggested as synapomorphies for the subfa…

SynapomorphybiologyDoryctinaeZoologyVenomHymenopteraMegaloproctusAnatomyVenom glandbiology.organism_classificationmedicine.anatomical_structureGeneticsmedicineAnimal Science and ZoologyMolecular BiologyBraconidaeDuct (anatomy)Ecology Evolution Behavior and SystematicsZoologica Scripta
researchProduct

A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura

2020

Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) is a thrombotic microangiopathy caused by inhibitory autoantibodies against ADAMTS13 protein. Until recently, the combination of plasma exchange (PEX) and immunosuppression has been the standard front-line treatment in this disorder. However, aTTP-related mortality, refractoriness, and relapse are still a matter of concern. Areas covered: The better understanding of the pathophysiological mechanisms of aTTP has allowed substantial improvements in the diagnosis and treatment of this disease. Recently, the novel anti-VWF nanobody caplacizumab has been approved for acute episodes of aTTP. Caplacizumab is capable to block the adh…

Thrombotic microangiopathyExacerbationvirusesmedicine.medical_treatmentADAMTS13 ProteinDiseaseBioinformaticsAutoantigens03 medical and health sciencesPlatelet Adhesiveness0302 clinical medicineFibrinolytic AgentsProtein DomainsCrotalid Venomsvon Willebrand FactormedicineHumansImmunologic FactorsMulticenter Studies as TopicLectins C-TypeMolecular Targeted TherapyDrug ApprovalClinical Trials as TopicAcquired Thrombotic Thrombocytopenic PurpuraPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryStandard treatmentfungiImmunosuppressionDrugs InvestigationalHematologyAptamers NucleotideSingle-Domain Antibodiesbiochemical phenomena metabolism and nutritionmedicine.diseaseCombined Modality TherapyRecombinant ProteinsADAMTS13AcetylcysteineTreatment Outcome030220 oncology & carcinogenesisDrug Therapy CombinationCaplacizumabbusinessImmunosuppressive Agents030215 immunologyExpert Review of Hematology
researchProduct

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1997

Abstract The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD4…

Time Factorsmedicine.medical_treatmentImmunologyCD40 LigandDown-RegulationVenomWasp VenomsImmunoglobulin ELigandsLymphocyte ActivationPeripheral blood mononuclear cellInterferon-gammaTh2 CellsAntigens CDT-Lymphocyte SubsetsmedicineImmunology and AllergyHumansLymphocyte CountRNA MessengerCD40 AntigensCD40Membrane GlycoproteinsbiologyReceptors IgEInterleukinAntibodies MonoclonalInsect Bites and StingsReceptors InterleukinAllergensTh1 CellsInterleukin-10Receptors Interleukin-4Interleukin 10Bee VenomsCytokineDesensitization ImmunologicImmunologyAntigens Surfacebiology.proteinInterleukin-4AntibodyEuropean journal of immunology
researchProduct

Haemolytic activity and characterization of nematocyst venom fromPelagia noctiluca(Cnidaria: Scyphozoa)

2013

We investigated the haemolytic capacity of the crude venom extracted from isolated nematocysts of Pelagia noctiluca (Cnidaria: Scyphozoa), and evidenced the proteic fractions responsible for this activity. The nematocyst venom was used at various concentrations to evaluate the haemolytic activity and the lysosomal membrane stability of red blood cells of two teleostean species treated with the extract. The nematocyst extract was assayed against erythrocytes of the two teleostean species living in different environments, Carassius auratus as a common freshwater species, and Liza aurata as a representative of seawater species. Experiments on the haemolytic activity of P. noctiluca in the pres…

biologyVenomScyphozoaAnatomybiology.organism_classificationPelagia noctilucaHaemolysischemistry.chemical_compoundBiochemistrychemistryCrude venom; haemolysis; HPLC analysis; nematocysts; Pelagia noctilucaCrude venom haemolysis HPLC analysis nematocysts Pelagia noctilucaAnimal Science and ZoologyNematocystCnidocyteSodium dodecyl sulfatePolyacrylamide gel electrophoresisItalian Journal of Zoology
researchProduct

Peptide–Membrane Interactions Monitored by Fluorescence Lifetime Imaging: A Study Case of Transportan 10

2021

The interest on detailed analysis of peptide-membrane interactions is of great interest in both fundamental and applied sciences as these may relate to both functional and pathogenic events. Such interactions are highly dynamic and spatially heterogeneous, making the investigation of the associated phenomena highly complex. The specific properties of membranes and peptide structural details, together with environmental conditions, may determine different events at the membrane interface, which will drive the fate of the peptide-membrane system. Here, we use an experimental approach based on the combination of spectroscopy and fluorescence microscopy methods to characterize the interactions …

chemistry.chemical_classificationFluorescence-lifetime imaging microscopyChemistryRecombinant Fusion ProteinsSpectrum AnalysisGalaninWasp VenomsPeptideSurfaces and InterfacesCondensed Matter PhysicsFluorescenceArticleMembraneMicroscopy FluorescenceAmphiphileElectrochemistryFluorescence microscopeHigh spatial resolutionBiophysicsPeptide−Membrane Interactions FLIM Transportan 10 PhasorGeneral Materials SciencePeptidesSpectroscopySpectroscopyLangmuir
researchProduct

Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtu…

2003

Disintegrins represent a group of cysteine-rich peptides occurring in Crotalidae and Viperidae snake venoms, and are potent antagonists of several integrin receptors. A novel disintegrin, obtustatin, was isolated from the venom of the Vipera lebetina obtusa viper, and represents the first potent and selective inhibitor of the binding of integrin alpha(1)beta(1) to collagen IV. The primary structure of obtustatin contains 41 amino acids and is the shortest disintegrin described to date. Obtustatin shares the pattern of cysteines of other short disintegrins. However, in contrast to known short disintegrins, the integrin-binding loop of obtustatin is two residues shorter and does not express t…

chemistry.chemical_classificationModels MolecularbiologyDisintegrinsMolecular Sequence DataProtein primary structureVenomViper VenomsViper VenomsBiochemistryAmino acidBiochemistrychemistryViperidaebiology.animalFor the RecordDisintegrinbiology.proteinViperidaeAnimalsHomology modelingAmino Acid SequenceMolecular BiologyPeptide sequenceOligopeptides
researchProduct

Use of two-dimensional thin-layer chromatography for the components study of poly(adenosine diphosphate ribose)

1990

Two-dimensional thin-layer chromatography on cellulose plates has been used for separating and quantifying the three adenosine derivatives: AMP, phosphoribosyl AMP (PRAMP), and (PR)2AMP obtained by venom phosphodiesterase digestion of poly(ADP-ribose). In vitro synthesized polymer, up to 300 derivatives in length were studied. Some parameters of the complexity of poly(ADP-ribose) could be deduced from our results: (i) The first branching point appears in fragments of approximately 21 derivatives in length. (ii) The branching points are located at regular distances of approximately 41 derivatives from each other.

chemistry.chemical_classificationPoly Adenosine Diphosphate RiboseChromatographyPolymersChemistryBiophysicsPoly Adenosine Diphosphate RiboseCell BiologyBranching pointsPolymerBiochemistryAdenosineAdenosine MonophosphateIn vitroThin-layer chromatographyVenom phosphodiesterasechemistry.chemical_compoundmedicineElectrophoresis Polyacrylamide GelChromatography Thin LayerCelluloseMolecular Biologymedicine.drugAnalytical Biochemistry
researchProduct

Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom

1971

An enzymatic complex can be formed by factors from guinea pig serum and cobra venom, which is able to activate C3 bypassing C1, C4 and C2. Formation and action of the enzyme are described. The action on C3 results in an activation of the terminal complement components and in membrane destruction provided suitable membrane receptors are available.

chemistry.chemical_classificationVenomsCell MembraneGuinea PigsImmunologySnakesComplement System ProteinsBiologyChromatography DEAE-CelluloseEnzymesComplement componentsComplement (complexity)Guinea pigEnzymeMembraneBiochemistrychemistryCell surface receptorAnimalsImmunology and AllergyMagnesiumFunction (biology)Cobra venomEuropean Journal of Immunology
researchProduct

Uncapping the N-terminus of a ubiquitous His-tag peptide enhances its Cu2+ binding affinity

2019

Metal complexes with an N-terminally free and N-terminally acetylated polyhistidine region of Echis ocellatus venom, with an interesting His-rich motif present in numerous metal binding proteins from all kingdoms of life (DHDHDHHHHHHPGSSV-NH2 and Ac-DHDHDHHHHHHPGSSV-NH2) show the role of the free amino group in the thermodynamic enhancement of Cu2+, Ni2+ and Zn2+ binding. In the studied sequences, Cu2+ can be coordinated by different sets of imidazole rings, and a 3–10 helix is detected in close proximity of Cu2+ binding sites. The complexes are more stable than those with a typical His6-tag, despite a similar copper(II) coordination mode in both cases.

inorganic chemicals010405 organic chemistryStereochemistryChemistryPeptide sequence tagVenom010402 general chemistry01 natural sciences0104 chemical sciencesInorganic ChemistryMetalN-terminuschemistry.chemical_compoundAcetylationvisual_artvisual_art.visual_art_mediumImidazoleBinding siteUncappingDalton Transactions
researchProduct

Comparison of the contractile effects of endothelin-1 and sarafotoxin S6b in goat isolated cerebral arteries

1992

1. The effects of endothelium-derived endothelin-1 and snake venom-derived sarafotoxin S6b, peptides with striking structural and functional similarities, were examined and compared in isolated middle cerebral arteries of goats. 2. Endothelin-1 and sarafotoxin S6b contracted cerebral arteries in a concentration-dependent manner. The potency of endothelin-1 (EC50 = 4.9 (3.9-6.2) x 10(-10) M) was about ten times higher than that of sarafotoxin S6b (EC50 = 5.5 (4.4-6.9) x 10(-9) M). The tension returned to basal values after repeated washings and contraction with endothelin-1 could be reproduced. Endothelin-1 and sarafotoxin S6b induced further contraction in arteries precontracted with prosta…

medicine.hormonemedicine.medical_specialtyContraction (grammar)IndomethacinCerebral arteriesProstacyclinViper Venomscomplex mixturesEndothelinsNicardipinechemistry.chemical_compoundInternal medicinemedicineAnimalsVasoconstrictor AgentsPharmacologyDose-Response Relationship DrugEndothelinsGoats3-Pyridinecarboxylic acid 14-dihydro-26-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)- Methyl esterCerebral ArteriesEndothelin 1EGTAEndocrinologychemistryVasoconstrictioncardiovascular systemFemaleEndothelium Vascularmedicine.symptomVasoconstrictionResearch Articlecirculatory and respiratory physiologymedicine.drugMuscle contractionBritish Journal of Pharmacology
researchProduct